Cardio Diagnostics Holdings, Inc. (CDIO) vs Niki BioSolutions, Inc. (NIKI)
Cardio Diagnostics Holdings, Inc. and Niki BioSolutions, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Niki BioSolutions, Inc. are of similar size ($6.2M and $5.7M). Niki BioSolutions, Inc. grew revenue faster over the last twelve months: 42.6% against −25.1%. Niki BioSolutions, Inc. has the higher net margin (−921.7% vs −44,312.3%) and the higher return on invested capital (0.00% vs −219.4%). Across the 15 metrics below, Niki BioSolutions, Inc. leads on 12 and Cardio Diagnostics Holdings, Inc. on 3.
Valuation
Profitability
| Metric | CDIO | NIKI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | (87.96%) | 65.16% |
| Operating margin | (44,230.82%) | 0.00% | 0.00% |
| Net margin | (44,312.33%) | (921.74%) | 0.00% |
| Free cash flow margin | (39,893.15%) | 0.00% | 0.00% |
| Return on equity | (75.44%) | 0.00% | (57.72%) |
| Return on assets | (70.62%) | 0.00% | (49.22%) |
| Return on invested capital | (219.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack